Inventor · disambiguated record
Martin Krueger
Also filed as: KRUEGER MARTIN
16 granted patents·5 pending applications·77 citations·filing 2001–2019
91Inventor score
Top patents by PatentIndex Score
21 records- 0184US7338958B2Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agentsSCHERING AG·Filed 2004·Granted Mar 4, 2008·19 cites·13 claims
- 0283US7202260B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridonesSCHERING AG·Filed 2004·Granted Apr 10, 2007·11 cites·14 claims
- 0381US7012081B2Anthranyl amides and their use as medicamentsSCHERING AG·Filed 2001·Granted Mar 14, 2006·14 cites·12 claims
- 0478US7429592B2Cyanoanthranilamide derivatives and the use thereof as medicamentsSCHERING AG·Filed 2002·Granted Sep 30, 2008·12 cites·10 claims
- 0576US7081468B2Ortho-substituted anthranilic acid amides and their use as medicamentsSCHERING AG·Filed 2001·Granted Jul 25, 2006·8 cites·4 claims
- 0674US7459470B2N-oxide anthranylamide derivatives and their use as medicamentsSCHERING AG·Filed 2002·Granted Dec 2, 2008·8 cites·10 claims
- 0773US7906533B2Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2005·Granted Mar 15, 2011·1 cites·22 claims
- 0871US8642611B2Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameHARTUNG INGO·Filed 2008·Granted Feb 4, 2014·2 cites·15 claims
- 0967US8198456B2Dihydropyridine derivatives as useful as protein kinase inhibitorsADLER MARC·Filed 2007·Granted Jun 12, 2012·2 cites·10 claims
- 1066US11618735B2Crystal forms of the monosodium salt of foramsulfuronBAYER CROPSCIENCE AG·Filed 2019·Granted Apr 4, 2023·0 cites·8 claims
- 1156US10472331B2Crystal forms of the monosodium salt of foramsulfuronBAYER CROPSCIENCE AG·Filed 2015·Granted Nov 12, 2019·0 cites·18 claims
- 1256US2007135489A1Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridonesHUTH ANDREAS·Filed 2007·Application pending·0 cites
- 1355US7902229B2Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2005·Granted Mar 8, 2011·0 cites·17 claims
- 1453US7479491B2Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitorsNOVARTIS AG·Filed 2004·Granted Jan 20, 2009·0 cites·3 claims
- 1552US2004039019A1Selected anthranilaminde pyridinamides and their use as pharmaceutical agentsSCHERING AG·Filed 2003·Application pending·0 cites
- 1646US8003655B2Substituted sulphoximines as TIE2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameBAYER SCHERING PHARMA AG·Filed 2007·Granted Aug 23, 2011·0 cites·23 claims
- 1745US7517894B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinesBAYER SCHERING PHARMA AG·Filed 2004·Granted Apr 14, 2009·0 cites·11 claims
- 1844US7572794B2Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2005·Granted Aug 11, 2009·0 cites·40 claims
- 1943US2005261343A1Anthranilamides and their use as pharmaceutical agentsKRUEGER MARTIN·Filed 2005·Application pending·0 cites
- 2043US2006014747A1Ortho-substituted anthranilic acid amides and their use as pharmaceutical agentsKRUEGER MARTIN·Filed 2005·Application pending·0 cites
- 2138US2011124680A1Novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitorsBOHLMANN ROLF·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Krueger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →